Latest ISN News

ISN News is brought to you by category and is updated regularly. Please select a news category from the list below, then select a news article to read.

As part of the Saving Young Lives Project* a peritoneal dialysis (PD) training workshop was held at St John’s Medical College Hospital in Bengaluru, India, from November 15-16, 2019.

The workshop aimed to empower pediatricians working in the community and in hospital settings with a skill-based approach to the management of a child with acute kidney injury (AKI). The hands-on course taught early detection of AKI, non-dialysis management for AKI, and acute peritoneal dialysis. A course book was produced to accompany the workshop.

Read an article about the way local solutions are saving young lives here.

18 pediatricians and 2 nurses from Northeast and South India, as well as neighboring Nepal, Sri Lanka, and Mauritius attended the course. Selection was made by course facilitators Dr. Arpana Iyengar, Dr. Anil Vasudevan, and Dr. Rajiv Sinha based on available expertise and existing resources within the regions.

ISN President Vivek Jha was a guest speaker at the training, discussing AKI challenges around the world.

The impact of the SYL Renal Basic Life Support Training Course and other SYL courses is monitored by inviting course delegates to participate in collecting data of their future AKI patients treated with PD.

*An ISN collaboration with SYL partner organizations: the International Paediatric Nephrology Association (IPNA), the European Peritoneal Dialysis Organisation (EuroPD), and International Society for Peritoneal Dialysis (ISPD).

As part of the Educational Ambassadors Program (EAP), the ISN supported Jaime Uribarri, from Mount Sinai School of Medicine, New York, to spend one week in May 2019 as ISN Educational Ambassador to train staff at the Hospital Nacional Guillermo Almenara in Lima, Peru.

The aim of the training was to increase knowledge about the nutritional management of CKD to reduce the prevalence of protein-energy wasting (PEW) and the complications that can arise from this pathology. Peruvian educational programs in nephrology generally do not include nutritional considerations; and, despite high levels of malnutrition in the Peruvian population, there is a lack of reliable data available to clinicians.

The ISN Ambassador gave lectures and practice-sessions on basic concepts in nutritional assessment in CKD patients, latest clinical and laboratory criteria for PEW, and best practices in management of PEW and related nutritional disorders.

Training provided through ISN’s EAP is intended to improve patient care in the host center and promote growth of the local nephrology practice.

Monday, 02 December 2019 10:22

Launch of ISN-Swiss-Cameroon Program

The International Society of Nephrology (ISN), the Swiss Society of Nephrology (SSN), and the Cameroon Society of Nephrology (CASONEPH), launched a new partnership earlier this year to establish a joint program of the ISN, Yaoundé 1 University, and Geneva University.

Dr James Tataw and Professor Patrick Saudan, from Geneva University, reported a successful start to the collaboration having spent 10 days in Yaoundé in November in order to launch the partnership between Geneva University, the Yaoundé 1 University, the nephrology units of Yaoundé General and University Teaching Hospitals, and the Cameroon Society of Nephrology. They met staff at the Faculty of Medicine and Biomedical Sciences of the Yaoundé 1 University, the Yaoundé General Hospital, and Yaoundé University teaching Hospital.

Progress has been made in the following areas:

  • Medical education: From November 1, 2020, a Fellow from Cameroon will begin a six-month residency to train in the maintenance of hemodialysis/peritoneal dialysis and acquire expertise in ultrasound procedures dedicated to hemodialysis in the nephrology unit of Geneva. Two further residencies are expected in November 2021 and 2022.
  • Clinical practice: The hemodialysis unit in Yaoundé University Teaching Hospital takes care of between 120-140 patients who are dialyzed twice a week. Talks were presented to the dialysis staff and a metric record was established. A handheld ultrasound transducer with vascular and cardiac probes was purchased for the dialysis unit.
  • A clinical research open-label trial assessing the interest of bicarbonate supplementation in addition to local standard care in pre-dialysis patients with chronic kidney disease was initiated in the nephrology units of Yaoundé General and University Teaching Hospitals: a donation of sodium bicarbonate has been made, a group of seven nephrologists have been designated to recruit from their outpatient clinics, and volunteer doctors will undertake the data management process. It’s planned that patients will be enrolled for the study from January 2020.

In order to investigate candidate hypotheses for chronic kidney disease of unknown etiology (CKDu), the ISN has supported a multidisciplinary group of nephrologists, epidemiologists, and occupational health and environmental scientists to form a consortium (i3C) to identify a coherent approach to studying CKDu and to provide recommendations for studies focusing on investigating causes. The team analyzed the most promising approaches with respect to designing field studies, integrating molecular analysis of biosamples into CKDu research, protecting the interests of study participants, and promoting collaboration. Research in this field has previously been challenging due to political circumstances, the marginalized nature of populations afflicted, and the scarcity of personnel and funding. This evaluation aims to facilitate studies that help understand chronic rates of CKDu in young and middle-aged individuals in certain regions of the world. Read the full paper at Kidney International (KI).

The BSN has joined the ISN as an ISN Collective Society alongside a valued group of Collective Societies. Members of the BSN will enjoy the full benefits of ISN membership for a tailored fee. As a Collective Society, BSN will work with the ISN to advance kidney health worldwide. In addition, this relation will provide an opportunity to develop materials in Portuguese for the ISN Academy.

Collective Society status increases global activity and visibility through ISN endorsement, priority consideration for managing joint events, and complimentary participation in the Global Village at the World Congress of Nephrology (WCN).

If you would like more information about the benefits of collective membership, please send an email to

ISN is pleased to announce a monthly series, “Milestones in Nephrology”, from the editorial team of Kidney International (KI). Through the course of 2020, this series will highlight 60 historical papers of importance to the nephrology community from the early days of KI.

Every month in 2020, five groundbreaking KI papers will be republished, discussed by an editor, and put into perspective of the most recent advances in the field.

This series sets the scene for the upcoming year of celebratory activities planned in 2020 to commemorate ISN’s 60th anniversary and the achievements ISN has made through its members and supporters.

Read More

Water is a forgotten nutrient. The ISN Academy is hosting Hydration For Health’s online courses. Hydration for Health is an initiative by Danone Nutricia Research which aims at raising public awareness on healthy hydration and encourage sustainable healthy hydration habits by sharing scientific research, educational materials, and practical tools.

The first course, “Hydration Basics”, focuses on basic knowledge of hydration with 4 presentations: water metabolism, the physiology of water homeostasis, hydration assessment methods and the pathophysiology of water. It’s led by Professor Ivan Tack M.D., Ph.D. Professor of Physiology, Head of the Clinical Physiology Department, Toulouse Medical School, Paul Sabatier University, France, (France) and Professor Stavros Kavouras, Ph.D, FACSM, FECSS (Professor of Nutrition at Arizona State University and Director of the Hydration Science Lab.

Learning objectives

  • To understand why water is a nutrient, and why it has been described as the forgotten nutrient.
  • To explain body water distribution and hormonal regulation.
  • To describe the hormonal profile of low water intake and how it impacts health.
  • To understand the use of different biomarkers in a laboratory or a free leaving condition
  • To cover the benefits and limitations of the blood urine biomarkers
  • To explain the use of urine color as a method hydration self-assessment in daily life.
  • To understand distribution and roles of water, osmotic pressure and cell volume regulation
  • To explain the renal action of AVP for water balance and discuss weather is renal water saving is a stress
  • To discuss optimal limits of hydration and fluid intake and study cases of low drinkers
  • To discuss the cost of the renal saving water

The second course, “Water and Fluid Intake” present the current dietary assessment methods, the results of the LiqIn7 database on fluid intake pattern in 13 countries and explores how to create an hydrogenic environment. It’s led by Dr. Joan Gandy Ph.D., RD, FBDA (UK), Freelance dietitian, UK Fellow of the British Dietetic Association, Hydration for Health Scientific Committee Member; Professor Homero Martinez, Ph.D. Micronutrient Forum,(Canada) ; and Dr. Isabelle Guelinckx, Ph.D., Msc, RD (former Fluid Intake Scientist, Danone Nutricia Research, France).

Learning Objectives:

  • To understand challenges when assessing fluid intake.
  • To familiarize with a validated methodology for assessing fluid intake
  • To understand how to make hydration part of your daily practice
  • To understand how to contribute to educating patients, understanding barriers and levers

Learn more here

At a joint meeting held during the 2019 SLANH congress in Lima, Peru, between the ISN President and Executive Director, the SLANH Steering Committees, and the members of the Latin American Board of ISN (LARB-ISN), ISN and SLANH agreed to extend and formalize their existing partnership to include collaboration on all ISN programs and activities, demonstrating their mutual commitment to the advancement of nephrology in the Latin American region.

This partnership seeks to advance regional capacity building through the ISN-SLANH Fellowships, Sister Renal Centers (SRC), CME meetings, Educational Ambassadors program (EA), Clinical Research projects, and the Kidney Care Network.

The collaboration also aims to increase the availability of educational content in Spanish and Portuguese on the ISN Academy and to develop and support CME meetings in Spanish and Portuguese held in Latin America.

In particular, this agreement is intended to encourage the training of Latin American Fellows within the region and to build partnerships between emerging and supporting Sister Renal Centers from the region. In both cases, the long-term objective is to create Nephrological Training Centers of excellence in Latin America.

The ISN is pleased to announce that it will be naming an ISN Fellowship in honor of Detlef Schlöndorff, MD, who died in October 2019.

Detlef Schlöndorff was a prolific renal investigator for over five decades and active in multiple leadership roles within the ISN, including as editor in chief of the Kidney International (KI). In 2019, he was awarded the ISN Jean Hamburger Award in recognition of his outstanding research in nephrology with a clinical emphasis. He trained and mentored over 50 fellows from around the globe, including some of the current world leaders in academic nephrology.

To honor and sustain Detlef’s commitment to training fellows, ISN invites donations to the Detlef Schlöndorff Fellowship fund, which will provide training to one physician per year from a low-resource country with the ultimate goal of improving the standards of care in the Fellow's home country upon their return and to help them become a leader in their field.

You can donate to the Detlef Schlöndorff Fellowship fund by PayPal. If you would like to donate by check or wire transfer, please contact Thomas Jacob, ISN Fellowship Program Coordinator, by email at

Tuesday, 26 November 2019 11:04

ISN Scientific Writing Course held in India

The 2019 ISN Scientific Writing Course (SWC) was held from Sep 30 to Oct 2 in Delhi, India. This event, supported by the Indian Society of Nephrology, was delivered to nephrologists from Nepal, Bangladesh, India, Ethiopia, Uganda and Kenya, to enhance their scientific writing skills.

Faculty at the three-day course included international and local experts in the field of scientific writing: Giovanni Strippoli, ISN Clinical Research Program Committee Chair, Arpana Iyengar, ISN Clinical Research Program Committee Deputy Chair and Course Director, Neesh Pannu, Scientific Program Working Group for WCN 2020 Chair of Sub-theme, Marcello Tonelli, Scientific Program Working Group WCN 2020 Chair, and Narayan Prasad, Secretary General of the Indian Society of nephrology.

The twelve participants received one-on-one mentoring from faculty on various aspects of preparing a manuscript for publication and rated the course as “extremely engaging”. They gave special thanks to ISN faculty member and course director, Dr Arpana, “for putting together an excellent course”.

The ISN Renal Pathology Working Group seeks applications from nephropathologists from low and low-to-middle resource countries (as defined by the World Bank) for travel bursaries in 2020.

Four awards of up to a maximum value of $1500 per person will be awarded to finance either:

  • a mini-sabbatical to provide short term in-depth study of renal pathology by immersion in an established renal pathology laboratory for a period of 2-4 weeks,


  • attendance at a major renal pathology course  at the World Congress of Nephrology (WCN) to be held in Abu Dhabi, or courses in New York, Amsterdam, Warsaw (see below)

In addition, the organizers of the Columbia University Renal Pathology Course have kindly offered five awards of remote internet-based access to live streaming of the presentations during the first three days of the course, from July 10-12, 2020. Online access to audiovisual recordings of the presentations will also be provided for one month following the course. These are not monetary awards.

Successful applicants should already have fundamental knowledge in renal pathology, and should be involved in, or have the opportunity to become involved in, diagnostic evaluation of renal biopsy specimens. The awards are only available to ISN members.

Applications should be submitted electronically by December 13, 2019.

Please address any questions to 

Find further details and eligibility criteria on the application form.

Major renal pathology courses:

  • The Renal Pathology Course (26 March) at the World Congress of Nephrology to be held in Abu Dhabi 26-29 March, 2020
  • The International Renal Pathology Congress to be held in Warsaw 15-18 April, 2020
  • The Columbia University Renal Pathology Course Renal Biopsy in Medical Diseases of the Kidney to be held in New York City 10-13 July, 2020
  • Another course of your choice – please add details.

All sessions of the 17th International Congress of Nephrology, Dialysis and Transplantation, held in collaboration with the International Society of Nephrology and Tabriz University of Medical Sciences, taking place in Tabiz, Iran, will be streamed live at the ISN Academy over the three days of the Congress from November 19-22, 2019.

If you are unable to attend the event, the live stream will be available from tomorrow here. 

Recordings of the sessions will also be available after the Congress.

Monday, 18 November 2019 12:27

ISN at Kidney Week 2019

Meaghan Lunney, from the University of Alberta, Canada, presenting the abstract on ISN’s Global Kidney Health Atlas 2019, “Current Status of ESKD Care in World Countries and Regions,” during the morning session on November 9 at Kidney Week 2019.

isn booth visitors

Thanks to all those who visited the ISN booth in Washington, as well as all the ISN volunteer leaders who met on-site to carry out the work of ISN.

Session two of the ISN Online Curriculum on Intensive Care Nephrology is now available on the ISN Academy.

In this session, the characteristic features of AKI due to acute tubular necrosis are reviewed. The learning objectives are:

  • to understand the pathophysiology of tubular epithelial cell injury and repair as well as the main renal hemodynamic changes encountered in ICU during shock, sepsis and mechanical ventilation
  • to know the diagnostic procedures for AKI diagnosis
  • to know the specificities of AKI due to sepsis, cytolytic drugs, and antibiotics
  • to recognize and treat AKI secondary to rhabdomyolysis and hemolysis

To illustrate these topics, two typical clinical cases are presented (one case of rhabdomyolysis, one case of vancomycin toxicity) with a discussion about therapeutic options and recommendations.

Learn More

Issa Al Salmi, from Oman, a member of the ISN Young Nephrologist Committee (YNC) as well as the Local Organizing Working group of the WCN 2020 in Abu Dhabi, was recently awarded the prestigious Editors' Choice award by the American Journal of Kidney Diseases (AJKD) for his research into the international variation, predictors, and outcomes of missed hemodialysis sessions. Since 2017, AJKD has recognized a small number of articles published within its journal, which the editors have selected to receive the Editors' Choice Award. This year, Issa’s paper was one of four original research studies selected for this prize.

abstract issa
Visual abstract of Issa’s study which received the award

A challenge to providing quality care to hemodialysis patients is that patients sometimes miss one or more of their thrice-weekly scheduled HD treatments. Issa and his team asked how missing hemodialysis treatments differs across countries, and how missing treatments relates to patient characteristics and outcomes. Using data from the Dialysis Outcomes and Practice Patterns Study (DOPPS), they showed that missing ≥1 hemodialysis treatment over four months varied greatly across countries (<1% in Italy & Japan; 24% in US), across facilities, by particular patient factors, and was associated with poorer outcomes.

The ISN YNC was established in 2007 with the aim of engaging the Society’s younger members, developing education, research, and leadership opportunities tailored specifically for this younger age group. Issa has been a member of the committee for the last five years. He is currently part of initiatives within the committee to better engage younger ISN members, and to encourage nephrologists and trainees from within his region, and worldwide, to become active members of the society. He hopes his award will inspire young nephrologists and trainees to become active members of the ISN and to participate in research to advance our understanding of kidney disease. Issa encourages young nephrologists to come together at the WCN 2020 in Abu Dhabi, to celebrate the work of young ISN members from across the world.

issa al salmi Issa Al Salmi receiving the AJKD Editor’s Choice Award at the American Society of Nephrology, 2019

Monday, 18 November 2019 08:54

ISN-ACT Toolkit to be launched at WCN 2020

As part of its aim to increase the number of international, high-quality clinical trials in nephrology informing the optimal prevention and treatment of kidney disease and its complications for the benefit of patients, the ISN-ACT (Advancing Clinical Trials) Committee is developing an online clinical trials toolkit to provide the nephrology community with a central and user-friendly resource on randomized clinical trials. This important project will be released at the ISN World Congress of Nephrology (WCN) in Abu Dhabi, in March 2020.

The ISN-ACT Committee has drawn on contributions and expertise from over a dozen nephrologists and researchers from five continents. The resulting toolkit will be a focal point for those interested in clinical trials, regardless of their level of experience. This instrument will be of significant use to those working in countries where there is limited clinical trial expertise.

ISN members can look forward to the first online clinical trials toolkit designed specifically for the global nephrology clinical research community. Attend WCN 2020 and be part of the launch and the first to access the toolkit online.

Monday, 04 November 2019 11:15

ISN in Washington for Kidney Week

ISN will have three booths at the ASN Kidney Week from November 5-10, 2019, in Washington, DC. There will be free access to KI (Kidney International) journals at the KI Booth (No. 2632). The ISN booth (No. 2634) will be presenting the Friends@WCN special registration offer, taking registrations for WCN’20, and renewing memberships. The World Kidney Day booth (2636) will provide a photo opportunity at the even

The ISN warmly congratulates its president, Professor Vivekanand Jha, for receiving the American Nephrologists of Indian Origin (ANIO) 2019 Award for Academic Excellence for his outstanding achievements in nephrology.

Professor Jha is the Executive Director at The George Institute for Global Health in India, and a James Martin Fellow at The George Institute for Global Health at the University of Oxford.

Professor Jha has wide-ranging research interests, including in comprehensive understanding of the implications of kidney diseases for global healthcare. He has collaborated with many organizations, notably the WHO, on clinical practice guidelines and advocacy papers to help develop affordable and sustainable primary and secondary kidney disease prevention tools. He lectures extensively around the world and is a prolific writer and editor.

The ISN Global Kidney Health Atlas (GKHA) 2019 manuscript “Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey” was published in The BMJ on October 31.

The second edition of the GKHA reports on global kidney health across 160 countries representing 98% of the world’s population.

The report focuses on care for end-stage kidney disease (ESKD). It highlights the growing burden of ESKD and the significant inequities in accessing appropriate treatment both globally and regionally: two-thirds of patients living with ESKD have no access to lifesaving treatment such as dialysis, kidney transplantation or conservative care because of socio-economic, and political factors.

The researchers recommend important strategies to tackle this problem, and advocate for a greater involvement of local and international stakeholder organizations towards an equitable and optimal care for ESKD around the world.

Bello Aminu K, Levin Adeera, Lunney Meaghan, Osman Mohamed A, Ye Feng, Ashuntantang Gloria E et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey BMJ 2019; 367 :l5873

The ISN Online Curriculum on Intensive Care Nephrology launches today, November 4.

Pathophysiological and clinical data, along with clinical case studies, will be presented in four sessions made available on the ISN Academy every two weeks between now and December 16.

The course, directed by Eric Rondeau, Professor at APHP - Hôpital Tenon, Paris, France, and ISN Council Member, looks at the pathophysiology of acute disorders of the kidney; water and electrolyte disorders in ICU; acute kidney injury; glomerular, vascular or interstitial acute kidney diseases; and, renal replacement therapy for AKI patients.

The four sessions are made up of six 15-minute instructional visual presentations and two progressive clinical cases each. There is a multiple-choice test before and after each session, a discussion forum, references and guidelines. CME credits will be provided upon completion of the curriculum.

The first session “Main mechanisms and presentations of water and electrolyte disorders” as well as the full program, can be found on the ISN Academy website:

Learn More

ISN was well represented at the 15th Congress of AFRAN which was recently held in Mombasa. The ISN President, Professor Vivek Jha, as well as numerous other leaders and members of the ISN community were in attendance.

This congress, jointly organized by the African Association of Nephrology (AFRAN) and the African Pediatric Nephrology Association (AFPNA), took place from September 25 to 28 and focused on “Improving Kidney Care in Africa.”

ISN supported five speakers through its CME Program and had a strong presence throughout the congress. It organized a widely-attended breakfast session to present the ISN community, hear testimonies from past Fellows, and discuss nephrology challenges in Africa. The ISN booth was a platform for inspiring conversations with the delegates, including young nephrologists and nurses, many of whom expressed their interest in joining and contributing to the society. The African Regional Board members met and discussed the ISN strategic framework as well as the most pressing challenges to overcome.

It was also an opportune moment to present the ISN Pioneer Award to Professor Akinkugbe, from Nigeria, for his outstanding achievements in the field of nephrology. Professor Akinkugbe is a pioneer nephrologist in Africa, publishing papers on hypertension and successful practice in acute peritoneal dialysis in 1966, well before haemodialysis became readily available on the continent. He is widely published on kidney disease and hypertension and trained the first generation of indigenously-taught nephrologists who would become leading figures in nephrology in Nigeria, inspiring a new generation of African doctors to take up nephrology. In his absence, the prize was handed to Ifeoma Ulasi, current president of the Nigerian Society of Nephrology, and a volunteer leader of ISN.

Vivek Jha reports: “This was a spectacular meeting, with a diversity of program topics, several parallel sessions, and expert speakers from around the world. The attendance in sessions was very good, including by nurses.”

The ISN congratulates 22 new 2019 Fellows after the second round of applications. The successful applicants come from all over the globe: Africa, Latin America, NIS and Russia, and South Asia.

The ISN fellowship program provides tailor-made training from host institutions to health care professionals from low-resource countries. The Fellows aim to improve kidney health care in their home countries by implementing their newly acquired knowledge and experience. Since 1985, over 800 nephrologists worldwide have benefited from both long and short-term ISN fellowships.

Training is given primarily in clinical nephrology and transplantation but other areas, such as pediatric nephrology and peritoneal dialysis, are also covered.

This year, the ISN awarded the first IACN-ISN-HKSN (International Association of Chinese Nephrologists; International Society of Nephrology; Hong Kong Society of Nephrology) scholarship within the Fellowship Program to Ling Pan from the in China. Ling Pan will undertake a three-month training course supervised by Dr Ming-Hui Zhao at the Beijing University Institute of Nephrology in China. This initiative supports young nephrologists living and working in China who are looking for short-term training in either their home country or Hong Kong and is co-funded by the International Association of Chinese Nephrologists (IACN) and the Hong Kong Society of Nephrology (HKSN) alongside the ISN.

ISN thanks the following sponsors for their involvement in this project: Asia Pacific Society of Nephrology (APSN); British Renal Association; Elsevier; International Association of Chinese Nephrologists (IACN); Hong Kong Society of Nephrology (HKSN); Kidneys for Life; Kidney Research UK; The Schrier Fund.

Please find below the full list of finalists and their host institutions. 

2019-2 Successful Fellows


First Name Last Name Home Country Host Country Host Institution
Mohamed AbdAlBary Egypt USA University of Kentucky Medical Center, Lexington
Sumit Acharya ​Nepal UK Manchester Royal Infirmary
Zoya Adam Kenya UK King's College Hospital, London
Adewale Adetunji Nigeria South Africa Red Cross War Memorial Children's Hospital, Cape Town
Areefa Alladin-Karan ​Guyana Canada Alberta Children's Hospital, Calgary
David Atuhe Uganda Kenya East African Kidney Institute, Nairobi
Rabeea Azmat Pakistan UK Manchester Royal Infirmary
Ndulue Chidozie Nigeria UK Royal Preston Hospital
Cynthia Garcia-Sanchez Mexico USA Northwestern University Medical School, Chicago
Oswald Habyarimana Rwanda India St. Johns Medical College Hospital, Bangalore
Abdul-Jalil Inusah Ghana South Africa Stellenbosch University and Tygerberg Hospital, Cape Town
Jayanivash Jayam India South Korea St. Mary's Hospital, Seoul
Amna Kononna Sudan South Africa University of Cape Town, Groote Schuur Hospital
Dominic Kumashie Ghana South Africa Stellenbosch University and Tygerberg Hospital, Cape Town
Peter Maritim Kenya South Africa Stellenbosch University and Tygerberg Hospital, Cape Town
Alfred Meremo Tanzania South Africa University of the Witwatersrand, Johannesburg
Thembisile Mosalakatane ​Botswana South Africa Red Cross War Memorial Children's Hospital, Cape Town
Anselme Poda Morocco / Burkina Faso France Hôpital Tenon, Paris
Abid Mubashir Sheikh ​Botswana South Africa University of Cape Town, Groote Schuur Hospital
Amar Swali Tanzania India Muljibhai Patel Urological Hospital, Nadiad
Thabang Tsenoli ​Lesotho South Africa University of Cape Town, Groote Schuur Hospital
Miranda Tsilosani ​Georgia USA Arkana Laboratories, Little Rock
Ling Pan China China Beijing University, Institute of Nephrology

The ISN Academy and the ISN Education Working Group is pleased to announce a new online educational initiative, KI on the Academy. The Academy will summarize one article per month, selected by the editors of the Kidney International, and present it as a video abstract. This concise video summary will be presented by the author and will be made available to ISN members on the day the article is published in the journal. The first video abstract will be presented today, October 21, on the article: “Acute Declines in eGFR and Mortality as well as Cardiovascular Outcomes in Patients with Heart Failure with Reduced Injection Fraction” by Wendy McCallum, Division of Nephrology, Tufts Medical Center.

Click here to learn more

Friday, 18 October 2019 09:34

OBITUARY: Detlef Schlöndorff


Nephrology community remembers Detlef Schlöndorff

Detlef Schlöndorff, MD, died of pancreatic cancer in New York City on October 16, 2019, surrounded by his family. He was a prolific renal investigator for over five decades, training and mentoring over 50 fellows from around the globe, including some of the current world leaders in academic nephrology. He received many prizes in recognition of his work: the Franz Volhard Medal of the German Nephrology Society, the Luis Hernando International Nephrology Award from the Spanish Renal Foundation, and the Jean Hamburger Award from the International Society of Nephrology (ISN). He was active in multiple leadership roles within the ISN, including as editor in chief of the Kidney International from 2012-2017.

Detlef was a warm, engaging, cultured academic. Held in esteem by hundreds of friends and colleagues worldwide and devoted to his family, he will be greatly missed by all in his extensive community.

The ISN deeply mourns his loss and offers its sincerest condolences to his family.

Angie Aguilar-Gonzalez, an ISN-H4KH new investigator, focused her research on an area in Guatemala with high incidences of renal disease of unknown cause.
Given the high variability of fluid intake across the globe and the health consequences of these variations, she chose to measure hydration patterns and renal function markers in a group of children and adolescents.

Recognizing that community engagement plays an important role in the success of research studies, Angie drew data for this sample through engagement with the local community. She was able to build collaborative relationships with regional stakeholders and health practitioners.

The project raised awareness of kidney health in the region. So far, 36 children are enrolled in the study and 400 people participated in the first “kidney walk” organized in Guatemala. Locals visited the health center asking how to evaluate their kidneys and prevent damage. Doctors responded by requesting information to improve diagnosis and treatment.

Angie acknowledged that the research project provided “a huge opportunity to grow professionally and to make a change in Guatemala”. She’s confident that it’s an important step towards the creation of Guatemala’s own renal research centre in the future.

ISN’s H4KH initiative is supported by Danone Nutricia Research to stimulate the interest of established and new researchers to explore the role of hydration in kidney health.

Find out more here:


Fergus Caskey represented the Executive Committee at the 15th BANTAO Congress in Skopje, North Macedonia, that took place in September. Dr. Caskey presented Halima Resic with the ISN 2019 Pioneer Award in recognition of her research into the effects of frailty and depression on the nutritional status of hemodialysis patients.

In addition to her roles as academic, researcher, and clinician, Professor Resic is an active ISN volunteer leader. ISN congratulates Professor Resic, and the organizers of BANTAO for providing a valuable platform to present innovative research in nephrology.

ISN is pleased to have supported several speakers to attend this event through the Continuing Medical Education (CME) Program: Vladimir Tesar from the Czech Republic, Raymond Vanholder from Belgium, and Rumeyza Kazancioglu from Turkey, all gave talks at the ISN CME session “Possibility and treatment of the CKD progression and complications.”

Meeting with Fergus

Source: Kidney International

Kitty J. Jager, Csaba Kovesdy, Robyn Langham, Mark Rosenberg, Vivekanand Jha, Carmine Zoccali



On a world scale the total number of individuals with chronic kidney disease (CKD), acute kidney injury (AKI), and those on renal replacement therapy (RRT) exceeds 850 million, a truly concerning figure that is twice the estimated number of people with diabetes worldwide and >20 times higher than the number of individuals affected by AIDS/HIV worldwide. Thus kidney diseases are one of the most common diseases worldwide. 

Read more

As part of the ISN’s capacity building partnership with the Indonesian Society of Nephrology (PERNEFRI), 2 doctors from Mohammad Hoesin General Hospital in Palembang, Indonesia (West Indoniesa) participated in a 2.5-day workshop held at Hospital Tuanku Ja’afar Seremban in Malaysia in June 2019. The Masterclass included a comprehensive training in standard operating procedure, management of complications and PD unit record keeping, with sessions facilitated by colleagues from Malaysia, Thailand and Australia.

Participation in this workshop PD Masterclass is part of the two hospitals’ multi-year training program together, training Mohammad Hoesin General in Palembang to become a ‘PD Center of Excellence’ in their Western region of Indonesia. Dr. Novadian Suhaimi and colleagues are leading this partnership in Palembang with Dr. Lily Mushahar and colleagues in Malaysia. This latest training of doctors at the PD Masterclass aims to improve PD management and outcomes in their Palembang hospital.

masterclass in malaysia compilation 

ISN Ex-President David Harris and Oceania and South East Asia Regional Board Chair Adrian Liew traveled to Jakarta, Indonesia on June 27th, 2019 to co-facilitate a one-day stakeholder meeting together with the Indonesian Society of Nephrology (PERNEFRI) with the goal of developing a roadmap for integrated kidney care in Indonesia. The meeting included 54 Participants from 10 different stakeholder groups across Indonesia, including the Ministry of Health, medical societies, patient groups and industry. An opening speech was given by Dr. Bambang Wibowo, Director General of Health Services of the Indonesian Ministry of Health, as well as by Dr. Aida Lydia Sutranto, PERNEFRI President and PERNEFRI Project Manager Dr. Rubin Surachno. 

The meeting consisted mainly of working sessions within the 3 pre-defined Focus Groups: CAPD, Kidney Disease Services (Reimbursements, Referral System and Regulations), and Pre-Dialysis Care and Prevention. Groups were asked to identify obstacles within these topics and develop action plans (with concrete timelines) to overstep these obstacles. All focus group sessions were observed and guided by ISN Leaders David Harris and Adrian Liew. By the end of the Stakeholder Meeting, each Focus Group had a final version of their focus group report and action plan that was presented to all stakeholder participants for final comments and consensus.

After this very successful stakeholder meeting, all stakeholders are in the process of finalizing an over-arching Roadmap for Integrated Kidney care in Indonesia, which aims to be released by the end of the year. 

Indonesia group photo

As part of a partnership with the Indonesian Society of Nephrology (PERNEFRI) aiming to increase access to integrated kidney care programs in Indonesia, the ISN and PERNEFRI have launched an initiative towards achieving ‘Centers of Excellence’ in Peritoneal Dialysis (PD) across Indonesia’s 13 geographically-diverse districts. 13 key institutions (one in each district) have been identified to partake in a multi-year training program paired with an expert Supporting Center from the surrounding region, ultimately aiming to achieve recognition as a PD Center of Excellence. These centers will then in turn train and support other hospitals in their respective district and be responsible for each district’s planning for the nation-wide PD registry. 

This initiative has garnered the support of Indonesia’s Ministry of Health, and capacity building activities have already begun in 8 of the 13 districts. The identified centers will be evaluated on an annual basis against pre-defined criteria to determine if they have achieved ‘Center of Excellence’ status. Activities are currently programmed for the next 2 years.

ISN PERNEFRI partnership

ISN logo press release   UHC HLM logo


ISN urges member states to truly uphold to their commitment to ‘leave no-one behind’. On NCDs, the declaration stresses mainly 5 disease groups without recognising that 55% of the global NCD burden arises from other NCDs, which often co-exist with and amplify the morbidity of the big 5. With 850.000.000 people affected worldwide, kidney disease is a key contributor to the global NCD burden as both a cause & consequence of other major NCDs and the leading cause of catastrophic health expenditure. If not addressed, it’s projected to become the 5th most common cause of YLL globally by 2040.

Multi-morbidities, shared disease clusters & social determinants are creating significant challenges for patient access to prevention & care ashealth systems are still configured to treat individual diseases.

ISN calls on member states to implement UHC plans which:

  • Strive for health systems that deliver people-centered, integrated, multisectoral and comprehensive services aimed at prevention, early detection and treatment of all NCDs and their risk factors, leaving no disease behind
  • Secure sustained human &financial resources to ensure a comprehensiveand holisticresponse to NCDs.

Vivek video

ISN President Vivek Jha at UNGA in NYC

As part of the Kidney Care Network (KCN) project, mini acute kidney injury (AKI) trainings ran by ISN reverse fellow Martyn Fredlund took place across rural hospitals in the Northeast region of South Africa throughout June and July 2019. Healthcare workers, among which nurses, doctors, internal medicine residents and medical/nurse graduate students across 10 community health centers were trained.

These training are part of the next phase of the 0by25 initiative, called the Kidney Care Network project, which implements certain interventions identified and proven as impactful by the 0by25 Pilot Feasibility Study into routine clinical care in selected sites in Bolivia, Nepal, Brazil and South Africa. This is done to improve the standard of care in acute kidney injury detection and management in these countries in a way that is appropriate and sustainable in the local setting.

Local experts train all relevant healthcare workers at the sites like in Mseleni, South Africa, using educational materials evaluated as successful in the Pilot Feasibility Project.

“We continue to collect data to measure the impact of this implementation project," says David Harris, co-lead of the KCN project, ‘this data will be crucial when engaging with local health authorities in the future to seek their support and ensure the interventions proposed become part of normal clinical care in the long term.’ South Africa began collecting data on AKI patients last July and already have 84 AKI patients recorded throughout the region to date.

Mseleni training on POCs

As part of the Kidney Care Network project, a two-day acute kidney injury (AKI) training was held in Santarém at the NACE-NUMETROP regional hospital on May 13-14, 2019 with approximately 30 healthcare workers, among which nurses, doctors, internal medicine residents and medical/nurse graduate students from 4 health care centers in the Amazonian state of Pará.

The training is part of the next phase of the 0by25 initiative, called the Kidney Care Network project, which implements certain interventions identified and proven as impactful by the 0by25 Pilot Feasibility Study into routine clinical care in selected sites in Bolivia, Nepal, Brazil and South Africa. This is done to improve the standard of care in acute kidney injury detection and management in these countries in a way that is appropriate and sustainable in the local setting.

Local experts train all relevant healthcare workers at the sites like in Santarém, Brazil, using educational materials evaluated as successful in the Pilot Feasibility Project.

‘We continue to collect data to measure the impact of this implementation project," says David Harris, co-lead of the Kidney Care Network project, ‘this data will be crucial when engaging with local health authorities in the future to seek their support and ensure the interventions proposed become part of normal clinical care in the long term.’ Brazil has begun collecting data on AKI patients this month and will do so for the next 1-2 years.


  Brazil Workshop 2019 1

            Brazil Workshop 2019 2  Brazil Workshop 2019 3

Dr. Rolando Claure Del Granado, Kidney Care Network (KCN) Project Lead in Bolivia, joined Dr. Raúl Plata, Regional Councilor of the Latin American Society of Nephrology and Hypertension (SLANH) at the Ministry of Health in La Paz on September 10th to meet with Dr. Adolfo Zarate, Head of the National Kidney Health Program and his team.

They presented data findings from the KCN project in Bolivia, and made the case to improve acute kidney injury (AKI) guidelines nationwide and get support for more training of Bolivian healthcare workers in kidney disease care.

Such national advocacy efforts are part of the next phase of the 0by25 initiative, called the Kidney Care Network project, which implements certain interventions identified and proven as impactful by the 0by25 Pilot Feasibility Study into routine clinical care in selected sites in Bolivia, Nepal, Brazil and South Africa. This is done to improve the standard of care in acute kidney injury detection and management in these countries in a way that is appropriate and sustainable in the local setting.

The KCN Bolivia site in Cochabamba launched last August 2018. After two AKI training sessions of 136 healthcare workers in the region, this Bolivia site has identified, treated and collected data on 446 AKI patients in the region.

The September visit in La Paz was very well received by the National Kidney Health Program. They were impressed with the results and cost-effectiveness of education and prevention programs for a renal disease like AKI. They are now working with Rolando and ISN leaders to improve Bolivia’s AKI guidelines, and to invest in diagnostic equipment like Point-of-Care (POC) devices to use throughout the country.

A second follow-up visit with the National Kidney Health Program and Minister of Health is planned for November 2019.  

In the meantime, the Bolivian KCN team is working on developing a Mobile App to facilitate diagnosing for healthcare workers, and they’ll begin collecting data of pediatric patients.

BoliviaKCNsiteRolandowithdoctorandpatient RolandoClaure BoliviaMoH DoctorinBoliviausingKCNeducationalmaterial

Given the ISN’s core mission of advancing worldwide kidney health, it is essential that it has a presence and voice at those key events that are shape global health policy. Few organizations are as influential as the United Nations. From September 17–24, 2019, the UN will hold its General Assembly in New York. Here, it will discuss its priorities for the coming year.

A key topic – and one of particular interest to The ISN – is the issue of Universal Health Coverage (UHC). Already endorsed by WHO, UHC is designed to ensure that all individuals and communities have access to essential health services – promotion, prevention, treatment, rehabilitation, and palliation - without suffering financial hardship. It now forms part of the UN’s 2030 Sustainable Development Goals.

On September 23, as part of the UN General Assembly, there will a High-Level Meeting dedicated to UHC. This will review progress to date and – importantly for The ISN – will set out the next steps to achieving UHC. For the first time, UN Member States plan to make a Political Declaration on UHC, confirming the commitment to this goal and providing guidelines for its delivery.

For the ISN, this High-Level Meeting represents a huge opportunity to progress its objective of advancing worldwide kidney health. Our President, Vivek Jha will take part, giving kidney health a voice at this pivotal event for global health. He will inform the assembled Ministers and Ambassadors on the importance of ensuring that kidney disease is an intrinsic part of future UHC plans. The ISN is the only kidney health organization invited to the meeting.

The Political Declaration on UHC will provide The ISN and other national & regional organisations with an invaluable tool in their future advocacy efforts, helping them hold national government to account on their commitments in this area.

To take full advantage of the many opinion leaders and opinion formers present for the UN General Assembly, The ISN is also co-hosting a high-level workshop entitled “Exploring Solutions For Multi-Morbidities Prevention And Control: The Case Of Circulatory Health”. ISN President, Vivek Jha, will be a keynote speaker on one of the two panel discussions. If you are in NYC you can register to the event by clicking here.

The meeting, held under the banner of the Coalition of Circulatory Health, has attracted participants from the World Heart Federation, the International Diabetes Federation, and the World Stroke organization. It will be a key element of The ISN efforts to push kidney disease up the pollical agenda.

You can follow developments at the United Nations General Assembly on the ISN Twitter feed (@ISNkidneycare) or by using the hashtag #UNGA

Follow Vivek Jha on @vjha126

Follow Charu Malik on @CharuMalik_ISN

Friday, 06 September 2019 08:05

ISN at SLANH 2019 in Lima, Perú

ISN President Vivekanand Jha and Executive Director Charu Malik will attend the upcoming 18th Latin American Congress on Nephrology and Hypertension organized by the Latin American Society of Nephrology and Hypertension and the Peruvian Society of Nephrology in Lima on September 12-15 2019.

Prof Jha will present the ISN Pioneer Award for Latin America to Dr Edgar Sanclemente of Colombia. The Pioneer Award is given to an individual doctors in recognition of their substantial contribution to the development of nephrology in their country or region.

Prof. Jha and other leading experts including Prof. Bernardo Rodriguez Iturbe (Venezuela) and Prof. Carmen Avila Casado (Mexico) will speak at the ISN hosted Regional Workshop on glomerulopathies.

During the congress, Prof. Jha and Dr. Malik will meet with leaders from SLANH and ISN Affiliate and Collective Societies to learn how ISN can continue supporting members in Latin America and forging strong relationships with the nephrology community in Latin America.

They will also meet with representatives of the ISN Sister Renal Centers, ISN Fellows, and individual members. If you are at the Congress, please drop by the ISN exhibit table to meet our leaders and to learn more about ISN activities and programs.

Learn more about the Congress

The ISN-KI Editorial Fellowship will be awarded annually by ISN in conjunction with Kidney International (KI) to two ISN members who are early-career researchers in nephrology, dialysis or kidney transplantation.

The 2019-20 ISN-KI Editorial Fellowship winners are Dr. Anna Francis, a pediatric nephrologist at Queensland Children Hospital and post-doctoral Fellow at the University of Sydney, Australia, and Dr. Sethu Madhavan, a nephrologist in Columbus, Ohio, and Assistant Professor at the Ohio State University Wexner Medical Center.

During their fellowship years, Drs. Francis and Madhavan will train with the editors at KI and KI Reports. They will learn how to critically assess a manuscript, work as part of a team to evaluate the priority of manuscripts in a broader context, and discover how to manage the editorial responsibilities of a highly cited, reputable medical journal.

The Fellowship will also offer the opportunity to the winners to present their Editorial experience at the ISN annual congress. The 2020 World Congress of Nephrology is in Abu Dhabi, from March 26 to 29.

Sethu Madhavan

Sethu Madhavan

This second edition of the ISN Global Kidney Health Atlas (GKHA) 2019 focuses on improving understanding of the regional burden of end-stage kidney disease (ESKD) and the capacity for care delivery.

The latest findings will help encourage relevant stakeholders across countries and regions to advocate for improved access to and quality of kidney care. The data have valuable policy implications, providing a benchmark for measuring country and regional progress in kidney care and encouraging member states to bridge regional and national gaps.

In June, ISN attended the 11th Hydration for Health (H4H) conference in Evian, France.

Kidney International (KI) is pleased to announce the publication of a study on hypertension, led by the ISN iNET-CKD (International Network of chronic kidney disease cohort studies). This study highlights considerable international variation in hypertension control and treatment in chronic kidney disease (CKD).

The International Society of Nephrology is very concerned about the current state of negotiations on the Political Declaration for the first United Nations High-Level Meeting on Universal Health Coverage (UN HLM on UHC).


Kidney disease, which affects over 850.000 million people worldwide, is the 11th leading cause of death globally and is projected to become the 5th most common cause of years of life lost globally, by 2040. Kidney disease is a rapidly growing health burden and poses a significant health care challenge for governments, particularly in low and middle income countries. Kidney disease is a cause and a consequence of other major NCDs, including heart disease and diabetes, and yet it has been neglected in global UHC discussions to date.


The international community cannot afford to miss yet another opportunity to take targeted action on kidney disease as an integral part of the global NCD policy response.

Thursday, 25 July 2019 09:54

August in KI: Take time out for reading

The editors of Kidney International (KI) would like to share a selection of articles from the August edition of the publication.

Audience CME Russia 2019The Russian Dialysis Society, with support from the ISN Continuous Medical Education Program (CME), organized its 13th National Conference, in conjunction with the 18th North-West Nephrology Summer School. It was a chance for doctors as well as students from medical schools across Russia to gain much-needed training across different areas of nephrology.

In July 2019, the second series of clinical trials curated by the ISN Advancing Clinical Trials (ISN-ACT) team will get us thinking about nephrology research and encourage more discussion about transplant, glomerular diseases and pediatric nephrology: from the role of EPO post-transplant, tacrolimus dosing in Asian transplant recipients to the optimal duration of steroids in pediatric nephrotic syndrome.

Group picture day CME Nigeria 2019With support from the ISN Continuing Medical Education (CME) Program, the University of Nigeria Teaching Hospital and the George Institute for Global Health in India organized a specific training course on interventional nephrology, specifically tailored to the needs of nephrologists in resource-poor settings.

The second ISN Global Kidney Policy Forum publication is now available. Building on the first ISN Global Kidney Policy Forum, which took place in Mexico City in 2017, participants in the 2019 Forum in Melbourne addressed equitable access to kidney care, including the prevention, detection and management in Australia, New Zealand, and South East Asian and Pacific Island countries.

This month, the first series of clinical trials curated by the ISN-Advancing Clinical Trials (ISN-ACT) team will get us thinking about nephrology research and encourage more discussion about chronic kidney disease, dialysis and hypertension: from PD catheter exit site care, the effectiveness of Roxadustat, to the initial treatment of hypertension in Sub-Saharan Africans and the role of CKD nurses in primary care.

ASN logo                  eraedta                      

    ISN logo press release 


July 9, 2019

Kidney Patients are Neglected in Clinical Trials

The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients. Over 850 million people suffer from kidney diseases worldwide, a number which signifies epidemic proportions, yet these patients are still ignored by investigators and initiators of clinical trials in all medical fields – and are thus excluded from clinical trials. ASN, ERA-EDTA and ISN, collaboratively aim to bring about a paradigm change in medical research and have launched an information campaign to that end.

Kidney diseases affect 850 million people worldwide, a figure twice as high as that of diabetes. Yet patients with chronic kidney disease (CKD) are still being excluded from clinical trials. This gives rise to severe problems, because many beneficial therapies cannot be authorised by regulatory authorities for this subgroup of patient, this means that the therapies in question cannot be prescribed for CKD patients. It is crucial, however, that CKD patients be eligible for new treatments, especially in the fields of diabetes, cardiovascular disease, cancer, and liver disease.

CKD is bidirectionally linked to cardiovascular disease, in that CKD engenders a high risk of cardiovascular complications, while heart disease may induce or aggravate CKD. CKD is also bidirectionally linked to neoplasia because, regardless of other factors, cancers or treatments targeting cancers may engender CKD, while CKD may predispose to cancer. Furthermore, there is a strong relationship between CKD and diabetes: over a third of all dialysis patients have suffered from diabetes for a long time, and their need for dialysis treatment results from the fact that diabetes has damaged the kidneys (a condition called diabetic nephropathy). As a public health epidemic, CKD patients require innovative therapies. It is highly problematic, therefore, if CKD patients cannot benefit from innovative therapies for diabetes, cancer or cardiovascular diseases.

Since 1964 the ERA EDTA maintains a Registry of Dialysis and Transplantation in Europe. Starting about 10 years ago, this Registry has extended its research to pre-dialysis CKD by establishing a consortium of existing CKD cohorts in Europe and in 2007 provided expert advice to the European commission by contributing to the European Global Health Report by putting in focus the CKD epidemic. In recent years the ERA EDTA has directly funded clinical trials in renal diseases and in dialysis patients.

‘The fact of the matter is that many innovative treatments fail to reach our patients’, explains Professor Carmine Zoccali, President of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA). ‘Let’s take SGLT inhibitors, a new group of antidiabetic drugs, as an example. We know from studies that these substances may protect kidney function, but they have not been tested in CKD patients with an eGFR below 30 ml/min. This means that kidney patients are excluded from therapies that might slow down the progression of CKD.’

When it comes to treatment of other illnesses and/or comorbidities, CKD patients should also have the same right to receive the best possible treatment as any other patients. However, the truth is that many new therapies are not tested on this subgroup, which means that CKD patients are unable to benefit from promising therapies. The International Society of Nephrology charged the research community with enrolling 30% of CKD patients by 2030. By encouraging the inclusion of CKD patients in high-quality clinical trials we can ensure they receive equal opportunity to receive evidence-based prevention and treatment of the disease. ‘It is a fact that the efficacy and the safety of treatments tested on patients without CKD cannot be assumed in CKD patients, and similarly that withholding treatment due to the presence of CKD may significantly and unfairly disadvantage those affected’, explains Professor David Harris, Past-President of the International Society of Nephrology. ‘We need studies that include CKD patients.’

The Kidney Health Initiative, the American Society of Nephrology’s public-private partnership with the US Food and Drug Administration, addresses this issue through its “Overcoming Barriers to Including Kidney Disease Patients in Cardiovascular Trials”. The project aims to understand the barriers to involving patients with kidney diseases into cardiovascular trials, with a focus on patients with advanced chronic kidney disease (stage 4) and end-stage renal diseases and identify strategies to overcome these challenges. The workgroup intends to submit their findings to a peer-reviewed medical journal in Summer 2019.

‘It is time for a change in clinical research practice’, confirms Professor Mark D. Okusa, Past-President of the American Society of Nephrology (ASN). ‘The already large and growing group of kidney patients cannot be ignored any longer in clinical trials.’ This is the reason why ASN ( ), ERA-EDTA ( ) and ISN ( ) have collaboratively launched an information campaign that aims to bring about this paradigm change.


Press Contact:
Dr. Bettina Albers
Jakobstrasse 38
99423 Weimar
Tel. +49 3643/ 7764-23
Fax +49 3643/ 7764-52

ASN Press Office
Christine Feheley
(202) 640-4638

Download the Press Release

Arvind and colleaguesAs members of the @ISNeducation Social Media team, nephrologists from institutes worldwide have taken on a stronger presence on social media. They are sharing knowledge more widely and gaining access to a global nephrology community, expanding their network, and making a global name for themselves.

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact


Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact